Phase Ib Study of Sintilimab Plus Anlotinib as First-line Therapy in Patients with Advanced Non-small Cell Lung Cancer.
暂无分享，去创建一个
B. Han | Yu Dong | Xueyan Zhang | H. Zhong | Zhi-qiang Gao | C. Shi | W. Nie | Yanwei Zhang | Yuchen Han | Wei Zhang | T. Chu | J. Qian | R. Zhong | Ya Chen | H. Qiang | Q. Chang | J. Teng | Bo Zhang | Z. Gao | Yi-ming Zhao